# Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer

> **NCT00537173** · — · TERMINATED · sponsor: **Hoosier Cancer Research Network** · enrollment: 11 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Core Biopsy
- **PROCEDURE:** Blood Collection
- **DRUG:** Paclitaxel
- **DRUG:** Avastin

## Key facts

- **NCT ID:** NCT00537173
- **Lead sponsor:** Hoosier Cancer Research Network
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2007-09
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Lack of Accrual
- **Last updated:** 2017-01-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00537173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00537173, "Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT00537173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*